Neuropathological findings in Down syndrome, Alzheimer’s disease and control patients with and without SARS-COV-2: preliminary findingsOriginal Paper Published on 2024-05-272024-09-05 Journal: Acta Neuropathologica [Category] update2024, [키워드] Alzheimer’s disease Brain Corona viruses COVID-19 Down syndrome glial cells neurologic symptoms SARS-CoV-2 [DOI] 10.1007/s00401-024-02743-9 PMC 바로가기 [Article Type] Original Paper
IgG1 glycosylation highlights premature aging in Down syndromeResearch Article Published on 2024-04-152024-09-05 Journal: Aging Cell [Category] update2024, [키워드] aging Down syndrome glycosylation Immunoglobulin [DOI] 10.1111/acel.14167 PMC 바로가기 [Article Type] Research Article
SARS-CoV-2 Infection Causes Heightened Disease Severity and Mortality in a Mouse Model of Down SyndromeArticle Published on 2024-02-282024-09-05 Journal: Biomedicines [Category] update2024, [키워드] COVID-19 Down syndrome mouse model Pathogenesis SARS-CoV-2 [DOI] 10.3390/biomedicines12030543 PMC 바로가기 [Article Type] Article
Cytomegalovirus Pneumonia in a Patient with Down SyndromeCase Report Published on 2024-01-302024-09-05 Journal: Medicina [Category] update2024, [키워드] cytomegalovirus Down syndrome Pneumonia [DOI] 10.3390/medicina60020242 PMC 바로가기 [Article Type] Case Report
Pneumonia vaccine response in individuals with Down syndrome at three specialty clinicsarticle Published on 2023-12-312024-09-01 Journal: American Journal of Medical Genetics Part C: Seminars in Medical Genetics [Category] 폐렴구균 감염증, [키워드] Down syndrome Pneumonia trisomy 21 vaccination [Article Type] article
Unraveling Down Syndrome: From Genetic Anomaly to Artificial Intelligence-Enhanced DiagnosisReview Published on 2023-12-122024-09-05 Journal: Biomedicines [Category] update2024, [키워드] artificial intelligence Cognitive impairment Comorbidity Diagnosis Down syndrome intellectual disability machine learning management neurodevelopment Neurological disorders [DOI] 10.3390/biomedicines11123284 PMC 바로가기 [Article Type] Review
Enhancing understanding of SARS-CoV-2 infection among individuals with Down syndrome: An integrative reviewarticle Published on 2023-08-212024-09-05 Journal: São Paulo Medical Journal [Category] update2024, [키워드] Coronavirus disease 2019 COVID-19 Cytokine storm in coronavirus disease 2019 Down syndrome Down syndrome comorbidities integrative review Outcomes of coronavirus disease 2019 in individuals with Down syndrome SARS-CoV-2 Systematic review [publication type] trisomy 21 [DOI] 10.1590/1516-3180.2023.0015.R1.230523 PMC 바로가기 [Article Type] article
Down Syndrome Outreach During the COVID-19 Pandemic: An Interprofessional Zoom WhatsApp Collaboration in SyriaEditorial Published on 2023-03-012023-07-10 Journal: Journal of pediatric health care : official public [Category] COVID19(2023년), [키워드] Down syndrome global outreach provider education. Syria [DOI] 10.1016/j.pedhc.2022.10.003 PMC 바로가기 [Article Type] Editorial
Decreased Antibody Response After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Patients With Down SyndromeObservational Study Published on 2022-09-042022-10-05 Journal: The Journal of Infectious Diseases [Category] SARS, 임상, 진단, [키워드] acute respiratory syndrome age antibody concentration Antibody Response BNT162b2 ChAdOx1 clinical coronavirus coronavirus 2 Course COVID-19 COVID-19 vaccination Decreased Down syndrome healthy control higher risk increase in increasing age Infection Messenger RNA Mortality mRNA mRNA vaccination prospective observational cohort respiratory response resulting risk SARS-CoV-2 SARS-CoV-2 spike SARS-CoV-2 vaccination Trial Vaccinations [DOI] 10.1093/infdis/jiac235 PMC 바로가기 [Article Type] Observational Study
SARS-CoV-2 vaccine humoral response in adults with Down syndrome다운증후군 성인의 SARS-CoV-2 백신 체액 반응Article Published on 2022-08-012022-09-12 Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), SARS, 진단, [키워드] age Antibody Response Antibody test Antibody titer baseline benefit binding domain booster dose coronavirus disease Course COVID-19 Down syndrome Efficacy evaluate first dose HCW Health care worker healthy humoral IgG antibody immune response male mRNA of BNT162b2 protective effect RBD regimen SARS-CoV-2 SARS-CoV-2 IgG SARS-CoV-2 vaccination SARS-CoV-2 vaccine second dose Siemen significantly subject treated two groups vaccination Vaccine were assessed [DOI] 10.1016/j.cmi.2022.04.008 PMC 바로가기 [Article Type] Article